+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Autoimmune Disease Diagnostics Market Size, Share & Trends Analysis Report by Type, Product, Test, End Use, Region, and Segment Forecasts, 2026-2033- Product Image
Autoimmune Disease Diagnostics Market Size, Share & Trends Analysis Report by Type, Product, Test, End Use, Region, and Segment Forecasts, 2026-2033- Product Image
New

Autoimmune Disease Diagnostics Market Size, Share & Trends Analysis Report by Type, Product, Test, End Use, Region, and Segment Forecasts, 2026-2033

  • PDF Icon

    Report

  • 129 Pages
  • January 2026
  • Region: Global
  • Grand View Research
  • ID: 6098042
REQUEST CUSTOMIZATION
Description Jump to:
The global autoimmune disease diagnostics market size was estimated at USD 6.07 billion in 2025 and is projected to reach USD 9.58 billion by 2033, growing at a CAGR of 5.84% from 2026 to 2033. The increasing prevalence of autoimmune disorders such as type 1 diabetes in newborn babies, coupled with the demand for rapid diagnostics, is the key driver accentuating growth.

In addition, there is an increasing focus on investments and funding for research related to autoimmune diseases, which further propels market growth. Furthermore, developing countries offer untapped opportunities for market expansion, presenting significant growth prospects in the years to come.

The establishment of technological advancements and the expansion of lab automation rates are anticipated to boost market growth. Clinicians are implementing advanced technology to conduct several tests at the same time with faster and more precise results.

Autoimmune diseases are a group of more than 100 chronic, debilitating conditions that affect approximately 3% of the US population. Some of the most common autoimmune diseases include obesity, cardiovascular diseases, type 2 diabetes mellitus, and all cancers. Thus, genetic factors, environmental influences, specific hormones, and susceptibility to certain infections are key contributors to the rising prevalence of autoimmune diseases globally. According to an article published by the National Health Council in September 2024, autoimmune diseases affect approximately 50 million Americans, and women account for 80% of this number. Given the inherent complexity involved in diagnosing these conditions, this figure is likely understated. More concerning is the fact that autoimmune diseases are approaching epidemic proportions, with several studies indicating annual growth rates in the range of 3%-12%.

An increasing rate of novel technological advancements and the corresponding emergence of laboratory automation technologies significantly contribute to market expansion. This trend is driven by the growing adoption of advanced technologies among clinicians, enabling them to conduct a wide range of tests while achieving faster and more accurate results. For instance, in January 2025, Werfen received FDA clearance for Aptiva Antiphospholipid Syndrome (APS) Immunoglobulin G (IgG) and Immunoglobulin M (IgM) Reagents. These assays enhance the accuracy of antiphospholipid syndrome (APS) diagnosis, addressing a significant unmet need in the diagnosis of autoimmune diseases.

In addition, the implementation of government initiatives across economies supports market developments. Work by organizations such as the Autoimmunity Centers of Excellence (ACE), the Cooperative Study Group for Autoimmune Disease Prevention (CSGADP), and the North American Rheumatoid Arthritis Consortium (NARAC) contributes to market growth by creating awareness among patients and healthcare professionals regarding proper diagnosis and treatment protocols.

The involvement of organizations such as the Autoimmunity Centers of Excellence, Cooperative Study Group for Autoimmune Disease Prevention, and North American Rheumatoid Arthritis Consortium in educating patients and healthcare professionals about proper diagnosis and treatment is anticipated to have a positive impact on market dynamics, as it promotes awareness and early intervention in autoimmune diseases. This, in turn, is expected to drive the growth of the autoimmune disease diagnostics market. Besides, favorable government initiatives aimed at increasing access to diagnostic tests, improving disease management and reducing healthcare costs, among other factors, are also expected to boost market growth during the forecast period.

Global Autoimmune Disease Diagnostics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global autoimmune disease diagnostics market report based on type, product, test, end use, and region.

Type Outlook (Revenue, USD Million, 2021-2033)

  • Systemic autoimmune disease diagnostics
  • Localized autoimmune disease diagnostics

Product Outlook (Revenue, USD Million, 2021-2033)

  • Instruments
  • Consumables and Assays

Test Outlook (Revenue, USD Million, 2021-2033)

  • Antinuclear antibody tests
  • Autoantibody tests
  • C-reactive Protein (CRP)
  • Complete blood count (CBC)
  • Urinalysis
  • Others

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals
  • Diagnostic centers
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Type segment
1.1.1.2. Product segment
1.1.1.3. Test segment
1.1.1.4. End use segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.6.3. Secondary Sources
1.6.4. Primary research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Type and Test Snapshot
2.3. Product and End use Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Presence of research funding programs
3.2.1.2. Presence of favorable government initiatives
3.2.1.3. Growing patient awareness levels
3.2.1.4. Technological innovation in the form of lab automation
3.2.2. Market Restraint Analysis
3.2.2.1. Slow diagnostic result turnaround times and lack of skilled healthcare practitioner
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
Chapter 4. Type Business Analysis
4.1. Autoimmune Disease Diagnostics Market: Type Movement Analysis
4.2. Systemic Autoimmune Disease Diagnostics
4.2.1. Systemic Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
4.2.2. Rheumatoid Arthritis Diagnostics
4.2.2.1. Rheumatoid Arthritis Diagnostics Market, 2021-2033 (USD Million)
4.2.3. Ankylosing Spondylitis Diagnostics
4.2.3.1. Ankylosing Spondylitis Diagnostics Market, 2021-2033 (USD Million)
4.2.4. Systemic Lupus Erythematosus (SLE) Diagnostics
4.2.4.1. Systemic Lupus Erythematosus (SLE) Diagnostics Market, 2021-2033 (USD Million)
4.2.5. Other Systemic Autoimmune Disease Diagnostics
4.2.5.1. Other Systemic Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
4.3. Localized Disease Diagnostics
4.3.1. Localized Disease Diagnostics Market, 2021-2033 (USD Million)
4.3.2. Multiple sclerosis diagnostics
4.3.2.1. Multiple sclerosis diagnostics Market, 2021-2033 (USD Million)
4.3.3. Type 1 Diabetes Diagnostics
4.3.3.1. Type 1 Diabetes Diagnostics Market, 2021-2033 (USD Million)
4.3.4. Hashimoto's Thyroiditis Diagnostics
4.3.4.1. Hashimoto's Thyroiditis Diagnostics Market, 2021-2033 (USD Million)
4.3.5. Idiopathic Thrombocytopenic Purpura (ITP) diagnostics
4.3.5.1. Idiopathic Thrombocytopenic Purpura (ITP) diagnostics Market, 2021-2033 (USD Million)
4.3.6. Other Localized Autoimmune Disease Diagnostics
4.3.6.1. Other Localized Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Chapter 5. Product Business Analysis
5.1. Autoimmune Disease Diagnostics Market: Product Movement Analysis
5.2. Instruments
5.2.1. Instruments Market, 2021-2033 (USD Million)
5.3. Consumables and Assays
5.3.1. Consumables and Assays Market, 2021-2033 (USD Million)
Chapter 6. Test Business Analysis
6.1. Autoimmune Disease Diagnostics Market: Test Movement Analysis
6.2. Antinuclear Antibody Tests
6.2.1. Antinuclear Antibody Tests Market, 2021-2033 (USD Million)
6.3. Autoantibody Tests
6.3.1. Autoantibody Tests Market, 2021-2033 (USD Million)
6.4. C-reactive Protein (CRP)
6.4.1. C-Reactive Protein (CRP) Market, 2021-2033 (USD Million)
6.5. Complete Blood Count (CBC)
6.5.1. Complete Blood Count (CBC) Market, 2021-2033 (USD Million)
6.6. Urinalysis
6.6.1. Urinalysis Market, 2021-2033 (USD Million)
6.7. Others
6.7.1. Others Market, 2021-2033 (USD Million)
Chapter 7. End Use Business Analysis
7.1. Autoimmune Disease Diagnostics Market: End Use Movement Analysis
7.2. Hospitals
7.2.1. Hospitals Market, 2021-2033 (USD Million)
7.3. Diagnostic Centers
7.3.1. Diagnostic Centers Market, 2021-2033 (USD Million)
7.4. Others
7.4.1. Others Market, 2021-2033 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Autoimmune Disease Diagnostics Market Share By Region, 2024 & 2030
8.2. North America
8.2.1. SWOT Analysis
8.2.2. North America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.2.3. U.S.
8.2.3.1. Key Country Dynamics
8.2.3.2. Target Disease Prevalence
8.2.3.3. Competitive Scenario
8.2.3.4. Regulatory Framework
8.2.3.5. U.S. Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.2.4. Canada
8.2.4.1. Key Country Dynamics
8.2.4.2. Target Disease Prevalence
8.2.4.3. Competitive Scenario
8.2.4.4. Regulatory Framework
8.2.4.5. Canada Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.2.5. Mexico
8.2.5.1. Key Country Dynamics
8.2.5.2. Target Disease Prevalence
8.2.5.3. Competitive Scenario
8.2.5.4. Regulatory Framework
8.2.5.5. Mexico Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.3. Europe
8.3.1. SWOT Analysis
8.3.2. Europe Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.3.3. UK
8.3.3.1. Key Country Dynamics
8.3.3.2. Target Disease Prevalence
8.3.3.3. Competitive Scenario
8.3.3.4. Regulatory Framework
8.3.3.5. UK Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.3.4. Germany
8.3.4.1. Key Country Dynamics
8.3.4.2. Target Disease Prevalence
8.3.4.3. Competitive Scenario
8.3.4.4. Regulatory Framework
8.3.4.5. Germany Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.3.5. France
8.3.5.1. Key Country Dynamics
8.3.5.2. Target Disease Prevalence
8.3.5.3. Competitive Scenario
8.3.5.4. Regulatory Framework
8.3.5.5. France Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.3.6. Italy
8.3.6.1. Key Country Dynamics
8.3.6.2. Target Disease Prevalence
8.3.6.3. Competitive Scenario
8.3.6.4. Regulatory Framework
8.3.6.5. Italy Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.3.7. Spain
8.3.7.1. Key Country Dynamics
8.3.7.2. Target Disease Prevalence
8.3.7.3. Competitive Scenario
8.3.7.4. Regulatory Framework
8.3.7.5. Spain Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.3.8. Sweden
8.3.8.1. Key Country Dynamics
8.3.8.2. Target Disease Prevalence
8.3.8.3. Competitive Scenario
8.3.8.4. Regulatory Framework
8.3.8.5. Sweden Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Target Disease Prevalence
8.3.9.3. Competitive Scenario
8.3.9.4. Regulatory Framework
8.3.9.5. Norway Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.3.10. Denmark
8.3.10.1. Key Country Dynamics
8.3.10.2. Target Disease Prevalence
8.3.10.3. Competitive Scenario
8.3.10.4. Regulatory Framework
8.3.10.5. Denmark Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.4. Asia Pacific
8.4.1. SWOT Analysis
8.4.2. Asia Pacific Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.4.3. Japan
8.4.3.1. Key Country Dynamics
8.4.3.2. Target Disease Prevalence
8.4.3.3. Competitive Scenario
8.4.3.4. Regulatory Framework
8.4.3.5. Japan Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.4.4. China
8.4.4.1. Key Country Dynamics
8.4.4.2. Target Disease Prevalence
8.4.4.3. Competitive Scenario
8.4.4.4. Regulatory Framework
8.4.4.5. China Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.4.5. India
8.4.5.1. Key Country Dynamics
8.4.5.2. Target Disease Prevalence
8.4.5.3. Competitive Scenario
8.4.5.4. Regulatory Framework
8.4.5.5. India Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.4.6. Australia
8.4.6.1. Key Country Dynamics
8.4.6.2. Target Disease Prevalence
8.4.6.3. Competitive Scenario
8.4.6.4. Regulatory Framework
8.4.6.5. Australia Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.4.7. Thailand
8.4.7.1. Key Country Dynamics
8.4.7.2. Target Disease Prevalence
8.4.7.3. Competitive Scenario
8.4.7.4. Regulatory Framework
8.4.7.5. Thailand Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.4.8. South Korea
8.4.8.1. Key Country Dynamics
8.4.8.2. Target Disease Prevalence
8.4.8.3. Competitive Scenario
8.4.8.4. Regulatory Framework
8.4.8.5. South Korea Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.5. Latin America
8.5.1. SWOT Analysis
8.5.2. Latin America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.5.3. Brazil
8.5.3.1. Key Country Dynamics
8.5.3.2. Target Disease Prevalence
8.5.3.3. Competitive Scenario
8.5.3.4. Regulatory Framework
8.5.3.5. Brazil Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.5.4. Argentina
8.5.4.1. Key Country Dynamics
8.5.4.2. Target Disease Prevalence
8.5.4.3. Competitive Scenario
8.5.4.4. Regulatory Framework
8.5.4.5. Argentina Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.6. Middle East and Africa
8.6.1. SWOT Analysis
8.6.2. Middle East and Africa Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.6.3. South Africa
8.6.3.1. Key Country Dynamics
8.6.3.2. Target Disease Prevalence
8.6.3.3. Competitive Scenario
8.6.3.4. Regulatory Framework
8.6.3.5. South Africa Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.6.4. Saudi Arabia
8.6.4.1. Key Country Dynamics
8.6.4.2. Target Disease Prevalence
8.6.4.3. Competitive Scenario
8.6.4.4. Regulatory Framework
8.6.4.5. Saudi Arabia Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.6.5. UAE
8.6.5.1. Key Country Dynamics
8.6.5.2. Target Disease Prevalence
8.6.5.3. Competitive Scenario
8.6.5.4. Regulatory Framework
8.6.5.5. UAE Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
8.6.6. Kuwait
8.6.6.1. Key Country Dynamics
8.6.6.2. Target Disease Prevalence
8.6.6.3. Competitive Scenario
8.6.6.4. Regulatory Framework
8.6.6.5. Kuwait Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market Share Analysis, 2024
9.4. Company Profiles/Listing
9.4.1. F. Hoffmann-La Roche Ltd
9.4.1.1. Overview
9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Siemens Healthineers AG
9.4.2.1. Overview
9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Abbott
9.4.3.1. Overview
9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Beckman Coulter, Inc.
9.4.4.1. Overview
9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Danaher Corporation
9.4.5.1. Overview
9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Quest Diagnostics
9.4.6.1. Overview
9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. EUROIMMUN Medizinische Labordiagnostika AG
9.4.7.1. Overview
9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Nova Diagnostics Pte Ltd.
9.4.8.1. Overview
9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. BIOMÉRIEUX
9.4.9.1. Overview
9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Hemagen Diagnostics, Inc.
9.4.10.1. Overview
9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives
List of Tables
TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviation
TABLE 3 Global Autoimmune Disease Diagnostics Market, By Region, 2021-2033 (USD Million)
TABLE 4 Global Autoimmune Disease Diagnostics Market, By Type, 2021-2033 (USD Million)
TABLE 5 Global Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 6 Global Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 7 Global Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 8 North America Autoimmune Disease Diagnostics Market, By Country, 2021-2033 (USD Million)
TABLE 9 North America Autoimmune Disease Diagnostics Market, By Type, 2021-2033 (USD Million)
TABLE 10 North America Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 11 North America Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 12 North America Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 13 U.S. Autoimmune Disease Diagnostics Market, by Type, 2021-2033 (USD Million)
TABLE 14 U.S. Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 15 U.S. Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 16 U.S. Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 17 Canada Autoimmune Disease Diagnostics Market, By Type, 2021-2033 (USD Million)
TABLE 18 Canada Autoimmune Disease Diagnostics Market, by Product, 2021-2033 (USD Million)
TABLE 19 Canada Autoimmune Disease Diagnostics Market, by Test, 2021-2033 (USD Million)
TABLE 20 Canada Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 21 Mexico Autoimmune Disease Diagnostics Market, by Type, 2021-2033 (USD Million)
TABLE 22 Mexico Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 23 Mexico Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 24 Mexico Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 25 Europe Autoimmune Disease Diagnostics Market, by country, 2021-2033 (USD Million)
TABLE 26 Europe Autoimmune Disease Diagnostics Market, by Type, 2021-2033 (USD Million)
TABLE 27 Europe Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 28 Europe Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 29 Europe Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 30 UK Autoimmune Disease Diagnostics Market, by Type, 2021-2033 (USD Million)
TABLE 31 UK Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 32 UK Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 33 UK Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 34 Germany Autoimmune Disease Diagnostics Market, by Type, 2021-2033 (USD Million)
TABLE 35 Germany Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 36 Germany Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 37 Germany Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 38 France Autoimmune Disease Diagnostics Market, by Type, 2021-2033 (USD Million)
TABLE 39 France Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 40 France Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 41 France Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 42 Italy Autoimmune Disease Diagnostics Market, by Type, 2021-2033 (USD Million)
TABLE 43 Italy Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 44 Italy Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 45 Italy Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 46 Spain Autoimmune Disease Diagnostics Market, by Type, 2021-2033 (USD Million)
TABLE 47 Spain Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 48 Spain Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 49 Spain Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 50 Sweden Autoimmune Disease Diagnostics Market, by Type, 2021-2033 (USD Million)
TABLE 51 Sweden Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 52 Sweden Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 53 Sweden Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 54 Norway Autoimmune Disease Diagnostics Market, by Type, 2021-2033 (USD Million)
TABLE 55 Norway Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 56 Norway Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 57 Norway Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 58 Denmark Autoimmune Disease Diagnostics Market, by Type, 2021-2033 (USD Million)
TABLE 59 Denmark Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 60 Denmark Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 61 Denmark Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 62 Asia Pacific Autoimmune Disease Diagnostics Market, by country, 2021-2033 (USD Million)
TABLE 63 Asia Pacific Autoimmune Disease Diagnostics Market, by Type, 2021-2033 (USD Million)
TABLE 64 Asia Pacific Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 65 Asia Pacific Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 66 Asia Pacific Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 67 Japan Autoimmune Disease Diagnostics Market, by Type, 2021-2033 (USD Million)
TABLE 68 Japan Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 69 Japan Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 70 Japan Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 71 China Autoimmune Disease Diagnostics Market, by Type, 2021-2033 (USD Million)
TABLE 72 China Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 73 China Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 74 China Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 75 India Autoimmune Disease Diagnostics Market, by Type, 2021-2033 (USD Million)
TABLE 76 India Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 77 India Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 78 India Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 79 Australia Autoimmune Disease Diagnostics Market, by Type, 2021-2033 (USD Million)
TABLE 80 Australia Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 81 Australia Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 82 Australia Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 83 Thailand Autoimmune Disease Diagnostics Market, by Type, 2021-2033 (USD Million)
TABLE 84 Thailand Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 85 Thailand Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 86 Thailand Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 87 South Korea Autoimmune Disease Diagnostics Market, by Type, 2021-2033 (USD Million)
TABLE 88 South Korea Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 89 South Korea Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 90 South Korea Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 91 Latin America Autoimmune Disease Diagnostics Market, by country, 2021-2033 (USD Million)
TABLE 92 Latin America Autoimmune Disease Diagnostics Market, by Type, 2021-2033 (USD Million)
TABLE 93 Latin America Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 94 Latin America Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 95 Latin America Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 96 Brazil Autoimmune Disease Diagnostics Market, by Type, 2021-2033 (USD Million)
TABLE 97 Brazil Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 98 Brazil Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 99 Brazil Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 100 Argentina Autoimmune Disease Diagnostics Market, by Type, 2021-2033 (USD Million)
TABLE 101 Argentina Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 102 Argentina Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 103 Argentina Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 104 Middle East and Africa Autoimmune Disease Diagnostics Market, by country, 2021-2033 (USD Million)
TABLE 105 Middle East and Africa Autoimmune Disease Diagnostics Market, by Type, 2021-2033 (USD Million)
TABLE 106 Middle East and Africa Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 107 Middle East and Africa Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 108 Middle East and Africa Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 109 South Africa Autoimmune Disease Diagnostics Market, by Type, 2021-2033 (USD Million)
TABLE 110 South Africa Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 111 South Africa Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 112 South Africa Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 113 Saudi Arabia Autoimmune Disease Diagnostics Market, by Type, 2021-2033 (USD Million)
TABLE 114 Saudi Arabia Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 115 Saudi Arabia Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 116 Saudi Arabia Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 117 UAE Autoimmune Disease Diagnostics Market, by Type, 2021-2033 (USD Million)
TABLE 118 UAE Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 119 UAE Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 120 UAE Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
TABLE 121 Kuwait Autoimmune Disease Diagnostics Market, by Type, 2021-2033 (USD)
TABLE 122 Kuwait Autoimmune Disease Diagnostics Market, By Product, 2021-2033 (USD Million)
TABLE 123 Kuwait Autoimmune Disease Diagnostics Market, By Test, 2021-2033 (USD Million)
TABLE 124 Kuwait Autoimmune Disease Diagnostics Market, By End Use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market Research Process
Figure 2 Information Procurement
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value Chain-Based Sizing & Forecasting
Figure 6 Market Formulation & Validation
Figure 7 Autoimmune Disease Diagnostics Market Segmentation
Figure 8 Market Driver Relevance Analysis (Current & Future Impact)
Figure 9 Market Restraint Relevance Analysis (Current & Future Impact)
Figure 10 Market Challenge Relevance Analysis (Current & Future Impact)
Figure 11 Penetration & Growth Prospect Mapping
Figure 12 Swot Analysis, By Factor (Political & Legal, Economic and Technological)
Figure 13 Porter’s Five Forces Analysis
Figure 14 Autoimmune Disease Diagnostics Market: Type Outlook and Key Takeaways
Figure 15 Autoimmune Disease Diagnostics Market: Type Movement Analysis & Market Share 2024 & 2030
Figure 16 Implementation Of the Amp Ra/SLE Program, By Research Phase
Figure 17 Global Systemic Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 18 Global Rheumatoid Arthritis Diagnostics Market, 2021-2033 (USD Million)
Figure 19 Global Ankylosing Spondylitis Diagnostics Market, 2021-2033 (USD Million)
Figure 20 Global Systemic Lupus Erythematosus (SLE) Diagnostics Market, 2021-2033 (USD Million)
Figure 21 Global Other Systemic Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 22 Global Localized Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 23 Global Multiple Sclerosis Diagnostics Market, 2021-2033 (USD Million)
Figure 24 Global Type 1 Diabetes Diagnostics Market, 2021-2033 (USD Million)
Figure 25 Global Hashimoto's Thyroiditis Diagnostics Market, 2013-2025 (USD Millio2021 - 2033 (USD Million)
Figure 26 Global Idiopathic Thrombocytopenic Purpura Diagnostics Market, 2021-2033 (USD Million)
Figure 27 Global Other Diagnostics Market, 2021-2033 (USD Million)
Figure 28 Autoimmune Disease Diagnostics Market: Product Outlook and Key Takeaways
Figure 29 Autoimmune Disease Diagnostics Market: Product Movement Analysis & Market Share
Figure 30 Global Instruments Market, 2021-2033 (USD Million)
Figure 31 Global Consumables and Assays Tests Market, 2021-2033 (USD Million)
Figure 32 Autoimmune Disease Diagnostics Market: Test Outlook and Key Takeaways
Figure 33 Autoimmune Disease Diagnostics Market: Test Movement Analysis & Market Share
Figure 34 Global Antinuclear Antibody Tests Market, 2021-2033 (USD Million)
Figure 35 Global Autoantibody Tests Market, 2021-2033 (USD Million)
Figure 36 Global C-Reactive Protein (CRP) Market, 2021-2033 (USD Million)
Figure 37 Global Complete Blood Count (CBC) Market, 2021-2033 (USD Million)
Figure 38 Global Urinalysis Market, 2021-2033 (USD Million)
Figure 39 Global Others Market, 2021-2033 (USD Million)
Figure 40 Autoimmune Disease Diagnostics Market: End Use Outlook and Key Takeaways
Figure 41 Autoimmune Disease Diagnostics Market: End Use Movement Analysis & Market Share
Figure 42 Global Hospitals Market, 2021-2033 (USD Million)
Figure 43 Global Diagnostic Centres Market, 2021-2033 (USD Million)
Figure 44 Global Others Market, 2021-2033 (USD Million)
Figure 45 Regional Marketplace: Key Takeaways
Figure 46 Regional Outlook, 2024 & 2030
Figure 47 Regional Market Dashboard
Figure 48 Regional Market Place: Key Takeaways
Figure 49 North America, Swot Analysis
Figure 50 Europe, Swot Analysis
Figure 51 Asia Pacific, Swot Analysis
Figure 52 Latin America, Swot Analysis
Figure 53 Middle East and Africa, Swot Analysis
Figure 54 North America
Figure 55 North America Autoimmune Disease Diagnostics Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 56 U.S. Key Country Dynamics
Figure 57 U.S. America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 58 Canada Key Country Dynamics
Figure 59 Canada America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 60 Mexico Key Country Dynamics
Figure 61 Mexico America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 62 Europe America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 63 UK Key Country Dynamics
Figure 64 UK America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 65 Germany Key Country Dynamics
Figure 66 Germany America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 67 France Key Country Dynamics
Figure 68 France America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 69 Italy Key Country Dynamics
Figure 70 Italy America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 71 Spain Key Country Dynamics
Figure 72 Spain America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 73 Sweden Key Country Dynamics
Figure 74 Sweden America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 75 Norway Key Country Dynamics
Figure 76 Norway America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 77 Denmark Key Country Dynamics
Figure 78 Denmark America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 79 Asia Pacific America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 80 Japan Key Country Dynamics
Figure 81 Japan America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 82 China Key Country Dynamics
Figure 83 China America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 84 India Key Country Dynamics
Figure 85 India America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 86 Australia Key Country Dynamics
Figure 87 Australia America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 88 Thailand Key Country Dynamics
Figure 89 Thailand America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 90 South Korea Key Country Dynamics
Figure 91 South Korea America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 92 Latin America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 93 Brazil Key Country Dynamics
Figure 94 Brazil America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 95 Argentina Key Country Dynamics
Figure 96 Argentina America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 97 Middle East and Africa America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 98 South Africa Key Country Dynamics
Figure 99 South Africa America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 100 Saudi Arabia Key Country Dynamics
Figure 101 Saudi Arabia America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 102 UAE Key Country Dynamics
Figure 103 UAE America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 104 Kuwait Key Country Dynamics
Figure 105 Kuwait America Autoimmune Disease Diagnostics Market, 2021-2033 (USD Million)
Figure 106 Strategy Mapping

Companies Mentioned

The leading players profiled in this Autoimmune Disease Diagnostics market report include:
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG
  • Abbott
  • Beckman Coulter, Inc.
  • Danaher Corporation
  • Quest Diagnostics
  • EUROIMMUN Medizinische Labordiagnostika AG
  • Nova Diagnostics Pte Ltd.
  • BIOMÉRIEUX
  • Hemagen Diagnostics, Inc.

Table Information

Report AttributeDetails
No. of Pages129
PublishedJanuary 2026
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 6.07 Billion
Forecasted Market Value ( USD ) by 2033 $ 9.58 Billion
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Autoimmune Disease Diagnostics Market - Global Forecast 2026-2032 - Product Image

Autoimmune Disease Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Allergy And Autoimmune Disease Diagnostics Market Size, Share & Trends Analysis Report By Product & Service (Allergy Diagnostics), By Test Type, By Diagnostics Type, By End Use, By Region, And Segment Forecasts, 2025 - 2033 - Product Image

Allergy And Autoimmune Disease Diagnostics Market Size, Share & Trends Analysis Report By Product & Service (Allergy Diagnostics), By Test Type, By Diagnostics Type, By End Use, By Region, And Segment Forecasts, 2025 - 2033

  • Report
  • 136 Pages
  • Global
From
Autoimmune Disease Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Autoimmune Disease Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 186 Pages
  • Global
From
Autoimmune Disease Diagnostics Market by Product, Test Type, Technology, Disease Type, End-user - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles, and Market Forecast, 2025-2035 - Product Image

Autoimmune Disease Diagnostics Market by Product, Test Type, Technology, Disease Type, End-user - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles, and Market Forecast, 2025-2035

  • Report
  • 180 Pages
  • Global
From
Autoimmune Disease Diagnostics Market - Products, Disease Types and Test Types - Product Image

Autoimmune Disease Diagnostics Market - Products, Disease Types and Test Types

  • Report
  • 338 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.